Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) EPS (Basic) (2016 - 2025)

Neuroone Medical Technologies' EPS (Basic) history spans 14 years, with the latest figure at -$0.03 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 150.0% year-over-year to -$0.03; the TTM value through Dec 2025 reached -$0.17, up 34.62%, while the annual FY2025 figure was -$0.09, 80.43% up from the prior year.
  • EPS (Basic) reached -$0.03 in Q4 2025 per NMTC's latest filing, up from -$0.04 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.06 in Q4 2024 to a low of -$0.25 in Q2 2021.
  • Average EPS (Basic) over 5 years is -$0.13, with a median of -$0.12 recorded in 2023.
  • Peak YoY movement for EPS (Basic): surged 142.86% in 2024, then crashed 150.0% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.18 in 2021, then soared by 38.89% to -$0.11 in 2022, then dropped by 27.27% to -$0.14 in 2023, then skyrocketed by 142.86% to $0.06 in 2024, then plummeted by 150.0% to -$0.03 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's EPS (Basic) are -$0.03 (Q4 2025), -$0.04 (Q3 2025), and -$0.03 (Q2 2025).